Cite Filings / ANIP / 0001023024-25-000035
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
DEF 14A

Proxy Statement

ANI PHARMACEUTICALS INC · Filed 2025-04-10 · Acc 0001023024-25-000035

Documents 1

  • DEF 14A Proxy Statement , anip-20250410.htm

Around this filing

  • 2026-04-09 DEF 14A Proxy Statement
  • 2025-04-14 4 SR. VP, GENERAL COUNSEL & SEC. sold 400 shares at $68.96 ($27,584)
  • 2025-04-10 SCHEDULE 13G/A Statement of Beneficial Ownership
  • 2025-04-10 ARS Annual Report to Security Holders
  • 2025-04-10 DEFA14A Proxy Materials
  • 2025-04-10 DEF 14A Proxy Statement
  • 2024-04-05 DEF 14A Proxy Statement

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
  • SEC Structured Data (opens in new tab)
Loading anip-20250410.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…